You are here

NextCure

NextCure goes all in on B7-H4, stopping other programs to challenge Big Pharma in ADC space

Fierce Biotech

Fri, 11/8/24 - 11:43 am

antibody-drug conjugate

NextCure Delays 2 Clinical Trials Due to Coronavirus

Motley Fool

Tue, 04/14/20 - 09:57 pm

clinical trials

immuno-oncology

What Does the Future Hold for Nextcure?

Motley Fool

Sat, 01/18/20 - 07:30 pm

SITC – the morning after the night before

EP Vantage

Mon, 11/11/19 - 07:51 pm

Early data on NextCure's immuno-oncology drug in lung cancer patients delights investors

Endpoints

Thu, 11/7/19 - 10:18 am

immuno-oncology

2 Small-Cap Biotech IPOs You Should Know About

Motley Fool

Thu, 07/18/19 - 02:23 pm

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

Thu, 05/9/19 - 11:06 am

clinical trials

Milestone Pharmaceuticals

Trevi Therapeutics

Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO

CP Wire

Mon, 04/29/19 - 10:04 am

immuno-oncology

Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO

Mon, 04/29/19 - 10:04 am

immuno-oncology

Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch

Endpoints

Mon, 04/15/19 - 12:11 pm

Applied Therapeutics

Milestone Pharmaceuticals

NextCure's macrophage-based alternative to T cell checkpoint inhibitors

BioCentury

Mon, 03/4/19 - 11:53 pm

T cell checkpoint inhibitors

Fresh from Eli Lilly deal, NextCure bags $93M for clinical push

Fierce Biotech

Tue, 11/13/18 - 09:58 am

Eli Lilly Commits $40M to NextCure in Hunt for New Cancer Drugs

Xconomy

Mon, 11/5/18 - 07:19 pm

cancer immunotherapy

drug development

4 Companies Pfizer Just Increased Its Stake In

Yahoo/Benzinga

Mon, 01/11/16 - 11:59 am

4D Molecular Therapeutics